Marinus Pharmaceuticals

Sailing ship struggling in a heavy storm with lightning

Marinus lays off 20% to steady ship after IV seizure med issues

Marinus is implementing a raft of cost-cutting measures in the wake of last month's phase 3 fail—including waving goodbye to a fifth of its workforce.

James Waldron May 8, 2024 9:42am

Marinus sells priority review voucher to Novo Nordisk for $110M

Jul 14, 2022 10:50am

Stability woes torpedo Marinus' phase 3 seizure timeline

Feb 23, 2022 7:15am

Marinus tees up phase 3 for rare epilepsy med

Aug 18, 2021 11:16am

Marinus signs $30M upfront deal with Orion for antiseizure med

Aug 3, 2021 3:55pm

Sinking Marinus gets a lifeline with new ganaxolone data

Jan 23, 2017 7:51am